Introduction
============

Graves' disease (GD) is one of the autoimmune thyroid diseases (AITDs) which affect 5% of the general population ([@b1-etm-04-03-0538]). GD is an autoimmune antibody-mediated, thyroid-specific autoimmune disease which causes thyroid gland tumefaction. GD patients make antibodies to the thyroid-stimulating hormone receptor leading to hyperthyroidism. People of Western countries (∼1.2%) and 0.25--1.09% of people of China are afflicted with GD ([@b2-etm-04-03-0538],[@b3-etm-04-03-0538]). Although environmental factors, such as infection ([@b4-etm-04-03-0538]) and stress, are very important in the process of Graves' disease in susceptible individuals, one study in twins revealed that ∼80% of the predisposition to GD is due to genetic factors ([@b5-etm-04-03-0538]). Several genetic loci have been implicated in the susceptibility to this disease. One of the associated genes is the cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene which consists of 4 exons and 3 introns. In 1997, Yanagawa *et al* ([@b6-etm-04-03-0538]), Marron *et al* ([@b7-etm-04-03-0538]) and Donner *et al* ([@b8-etm-04-03-0538]) initially reported that there was an association between CTLA4 and Graves' disease. The CTLA-4 gene is located on the long arm of chromosome 2q33 and belongs to the immunoglobulin superfamily. Since the CTLA-4 protein transmits an inhibitory signal to T-cells, it has a strong susceptibility in autoimmunity. One of the CTLA-4 gene polymorphisms is located on exon 1 +49, which causes a threonine to alanine substitution in codon 17 (codon 17 T/A). To date, the CTLA-4 +49A/G polymorphism has been studied in different and numerous groups in humans, and a potential association with GD has been found in many results ([@b6-etm-04-03-0538]--[@b36-etm-04-03-0538]). However, some results suggest that there is no association between CTLA-4 +49A/G polymorphism and GD ([@b37-etm-04-03-0538]--[@b46-etm-04-03-0538]). Thus, the results are still inconsistent. Another problem is that these published studies only refer to a rather modest sample size that limits their significance. Utilizing the advantage of meta-analysis, a powerful method for quantitatively summarizing different study results, we combined the data for analysis and increased the sample size to a reasonable level. In this study, we conducted a meta-analysis to quantitatively assess the effect of the CTLA-4 +49A/G polymorphism on the risk of GD.

Materials and methods
=====================

Publication search
------------------

PubMed was searched using the terms 'CTLA 4', 'Graves' and 'polymorphism' or 'CTLA4', 'Graves' and 'polymorphism' or 'cytotoxic T lymphocyte', 'Graves' and 'polymorphism' (the last search update was on March 11, 2012). Case-control studies containing available genotype frequencies of 49A/G were chosen. Additional studies were identified by a manual search of the references of the original studies.

Statistic analysis
------------------

For the control group of each study, the observed genotype frequencies of the CTLA-4 +49A/G polymorphism were assessed for Hardy-Weinberg equilibrium using the χ^2^ test. The strength of association between the +49A/G polymorphism of the CTLA-4 gene and GD was assessed by calculating crude odds ratios (ORs) with 95% confidence intervals (CIs). The pooled ORs were performed for the additive genetic model (G vs. A), dominant model (G/G+G/A vs. A/A) and recessive model (G/G vs. G/A+A/A), respectively. Heterogeneity assumption was checked by a χ^2^-based Q-test. A p-value of \<0.05 for the Q-test indicated a lack of heterogeneity among the studies; the summary OR estimate of each study was calculated by the random effects model ([@b47-etm-04-03-0538],[@b48-etm-04-03-0538]). The potential for publication bias was examined by Begg's test (funnel plot method) and Egger's linear regression test (p\<0.05 was considered representative of statistical significance) ([@b49-etm-04-03-0538]). All statistical analyses were performed with Stata software (version 11.0; Stata Corporation, College Station, TX).

Results
=======

Eligible studies
----------------

We identified 42 case-control studies concerning the association between the CTLA-4 +49A/G polymorphism and GD, which included 8,288 GD cases and 9,372 controls. These data were used in our meta-analysis ([Table I](#t1-etm-04-03-0538){ref-type="table"}). The distribution of genotypes in the controls of all the studies was in agreement with Hardy-Weinberg equilibrium.

Meta-analysis
-------------

The results of the association between the CTLA-4 +49A/G polymorphism and GD and the heterogeneity test are shown in [Table II](#t2-etm-04-03-0538){ref-type="table"}. The overall results suggest that the variant genotypes were highly associated (p\<0.01) with GD risk in all genetic models \[additive model: OR, 1.443; 95% CI, 1.319--1.578; p\<0.001 ([Fig. 1](#f1-etm-04-03-0538){ref-type="fig"}); recessive model: OR, 1.589; 95% CI, 1.396--1.808; p\<0.001 ([Fig. 2](#f2-etm-04-03-0538){ref-type="fig"}); dominant model: OR, 1.621; 95% CI, 1.430--1.837; p\<0.001 ([Fig. 3](#f3-etm-04-03-0538){ref-type="fig"})\]. Similarly, in subgroup analyses for ethnicity (Caucasians, Asians), the results were positive.

Publication bias
----------------

Funnel plot and Egger's test were performed to estimate the publication bias of studies. The results of Egger's test provided statistical evidence for funnel plot symmetry (for G/G+G/A vs. A/A, p=0.166) ([Table II](#t2-etm-04-03-0538){ref-type="table"}).

Discussion
==========

This meta-analysis examined the association of the CTLA-4 +49A/G polymorphism with GD and included 8,288 GD cases and 9,372 controls. Three studies were eliminated from the total 42 studies due to a p-value of \<0.05 (p-value for Hardy-Weinberg equilibrium in control group) in these studies which induced significant publication bias. The results of Egger's test provided statistical evidence for funnel plot symmetry (for G/G+G/A vs. A/A, p=0.166). The overall results suggest that the variant genotypes were highly associated (p\<0.01) with GD risk in all genetic models (additive model: OR, 1.443; 95% CI, 1.319--1.578; p\<0.001; recessive model: OR, 1.589; 95% CI, 1.396--1.808; p\<0.001; dominant model: OR, 1.621; 95% CI, 1.430--1.837; p\<0.001). Similarly, in subgroup analyses for ethnicity (Caucasians, Asians), the results were positive.

GD is a disease with significant clinical consequences. The mechanism of GD is still relatively unknown. Although environmental factors, such as infection ([@b4-etm-04-03-0538]) and stress, are important in the process of Graves' disease in susceptible individuals, one study in twins suggests that ∼80% of the predisposition to GD is due to genetic factors ([@b5-etm-04-03-0538]). Single nucleotide polymorphisms (SNPs) can be used as a tool for investigating genetic variations and disease susceptibility. GD is an autoimmune antibody-mediated, thyroid-specific autoimmune disease. The CTLA-4 protein can transmit an inhibitory signal to T-cells and has a strong susceptibility in autoimmunity. CTLA-4 protein has recently been described as a gatekeeper of conjugation timing and reduced conjugation may protect against prolonged contact periods of cytotoxic T lymphocytes with autoantigen-defined targets ([@b50-etm-04-03-0538]). It has been in the centre of attention for its key role in autoimmunity. The +49A/G polymorphism is one of the CTLA-4 three forms of polymorphisms. To date, a multitude of different studies were carried out concerning the association between the CTLA-4 +49A/G polymorphism and GD, but the results are inconsistent. In many studies ([@b6-etm-04-03-0538]--[@b36-etm-04-03-0538]) the results are positive, however in others ([@b37-etm-04-03-0538]--[@b46-etm-04-03-0538]) the results are negative.

This meta-analysis revealed a highly significant (p\<0.01) association between the CTLA-4 +49A/G polymorphism and GD risk, in both Asian and Caucasian subgroups. In conclusion, this meta-analysis suggests that the CTLA-4 +49A/G polymorphism is potentially associated with the risk of GD among Caucasians and Asians. Future, well-designed, large scale studies are necessary to validate this association in different populations.
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###### 

Distribution of the CTLA-4 +49A/G genotype for patients with Graves' disease and the controls.

  Population   Ethnicity or origin                  Study                                                     GD    Control                            
  ------------ ------------------------------------ -------------------------------------------------- ------ ----- --------- ------ ----- ----- ----- ----------
  Caucasian    South Indian                         Veeramuthumari *et al* ([@b9-etm-04-03-0538])      2011   11    37        32     29    25    26    0.000819
  Asian        Thai                                 Kimkong *et al* ([@b37-etm-04-03-0538])            2011   22    49        61     26    73    54    0.875319
  Asian        Chinese Han                          Zhao *et al* ([@b10-etm-04-03-0538])               2010   104   730       1030   156   823   945   0.211832
  Asian        Japanese                             Kimura *et al* ([@b11-etm-04-03-0538])             2009   62    143       210    142   358   295   0.067982
  Caucasian    Iranian                              Khalilzadeh *et al* ([@b12-etm-04-03-0538])        2009   48    43        14     75    25    3     0.606930
  Caucasian    Iranian                              Esteghamati *et al* ([@b13-etm-04-03-0538])        2009   114   71        20     75    25    3     0.606930
  Others       Brazilian                            Namo Cury *et al* ([@b38-etm-04-03-0538])          2008   43    58        15     39    32    7     0.905523
  Asian        Chinese                              Chong *et al* ([@b14-etm-04-03-0538])              2008   7     73        97     24    56    71    0.028090
  Asian        Taiwanese                            Wang *et al* ([@b15-etm-04-03-0538])               2007   15    69        124    18    77    97    0.633099
  Asian        Chinese                              Zhang *et al* ([@b16-etm-04-03-0538])              2006   2     29        58     7     26    27    0.846451
  Caucasian    Turkish                              Tanrikulu *et al* ([@b17-etm-04-03-0538])          2006   48    38        11     42    34    14    0.120930
  Asian        Chinese                              Han *et al* ([@b18-etm-04-03-0538])                2006   33    95        135    32    89    75    0.520341
  Asian        Korean                               Cho *et al* ([@b39-etm-04-03-0538])                2006   16    112       160    30    197   244   0.240107
  Asian        Taiwanese                            Weng *et al* ([@b40-etm-04-03-0538])               2005   8     53        46     15    58    28    0.091603
  Caucasian    Turkish                              Sahin *et al* ([@b19-etm-04-03-0538])              2005   29    33        15     43    48    7     0.189953
  Caucasian    Italian                              Petrone *et al* ([@b20-etm-04-03-0538])            2005   59    68        23     139   138   24    0.201228
  Asian        Japanese                             Iwama *et al* ([@b41-etm-04-03-0538])              2005   17    25        1      78    88    34    0.287293
  Asian        Taiwanese                            Wang *et al* ([@b21-etm-04-03-0538])               2004   18    72        81     11    50    87    0.316477
  Caucasian    Lebanese                             Nakkash-Chmaisse *et al* ([@b22-etm-04-03-0538])   2004   8     23        3      24    14    0     0.163933
  Caucasian    Polish                               Frydecka *et al* ([@b42-etm-04-03-0538])           2004   32    50        17     50    84    20    0.096480
  Caucasian    White                                Vaidya *et al* ([@b23-etm-04-03-0538])             2003   88    139       74     146   158   45    0.825642
  Asian        Japanese                             Mochizuki *et al* ([@b24-etm-04-03-0538])          2003   1     6         13     12    27    21    0.539129
  Caucasian    Iranian                              Kalantari *et al* ([@b25-etm-04-03-0538])          2003   21    49        20     30    53    30    0.510214
  Caucasian    Polish                               Bednarczuk *et al* ([@b26-etm-04-03-0538])         2003   75    123       66     77    85    32    0.303455
  Asian        Japanese                             Bednarczuk *et al* ([@b26-etm-04-03-0538])         2003   28    140       151    15    63    34    0.093804
  Asian        Chinese                              Yung *et al* ([@b27-etm-04-03-0538])               2002   3     54        66     23    59    76    0.046372
  Caucasian    USA                                  Kouki *et al* ([@b28-etm-04-03-0538])              2002   22    67        31     30    36    14    0.576150
  Asian        Japanese                             Kinjo *et al* ([@b32-etm-04-03-0538])              2002   32    62        50     38    46    26    0.107271
  Caucasian    Tunisian                             Hadj Kacem *et al* ([@b30-etm-04-03-0538])         2001   31    63        50     26    94    85    0.998814
  Caucasian    UK Caucasian                         Allahabadia *et al* ([@b43-etm-04-03-0538])        2001   136   262       86     192   198   34    0.081624
  Others       African, American, Hispanic, Asian   Villanueva *et al* ([@b44-etm-04-03-0538])         2000   42    67        28     53    52    16    0.568526
  Asian        Korean                               Park *et al* ([@b31-etm-04-03-0538])               2000   5     35        57     26    75    98    0.061219
  Others       Not specified                        Kouki *et al* ([@b32-etm-04-03-0538])              2000   8     29        8      15    23    5     0.390573
  Caucasian    Moscow                               Chistyakov *et al* ([@b33-etm-04-03-0538])         2000   6     22        50     25    38    30    0.081864
  Others       African-American                     Chen *et al* ([@b45-etm-04-03-0538])               2000   20    25        4      23    19    5     0.718804
  Caucasian    UK                                   Heward *et al* ([@b34-etm-04-03-0538])             1999   122   192       65     164   171   28    0.067423
  Caucasian    White                                Djilali-Saiah *et al* ([@b46-etm-04-03-0538])      1998   23    37        13     47    37    16    0.069793
  Caucasian    German, Canadian                     Braun *et al* ([@b35-etm-04-03-0538])              1998   22    56        25     52    48    21    0.096985
  Asian        Japanese                             Awata *et al* ([@b36-etm-04-03-0538])              1998   11    44        57     58    197   170   0.938310
  Asian        Japanese                             Yanagawa *et al* ([@b6-etm-04-03-0538])            1997   11    64        78     34    88    78    0.287293
  Asian        Chinese                              Marron *et al* ([@b7-etm-04-03-0538])              1997   1     11        16     6     39    49    0.632129
  Caucasian    German, Canadian                     Donner *et al* ([@b8-etm-04-03-0538])              1997   81    161       63     135   149   41    0.990935

p-value for Hardy-Weinberg equilibrium in the control group. GD, Graves' disease.

###### 

ORs and 95% CI for the CTLA-4 +49A/G polymorphism for different genetic models in patients with Graves' disease.

  Genetic model                    Population   Pooled OR        (95% CI)         P-value   Heterogeneity P-value   Begg's test P-value   Egger's test P-value
  -------------------------------- ------------ ---------------- ---------------- --------- ----------------------- --------------------- ----------------------
  Additive (G vs. A)               Asian        1.347            (1.203--1.507)   \<0.001   0.003                   0.323                 0.373
  Caucasian                        1.543        (1.324--1.798)   \<0.001          \<0.001   0.426                   0.788                 
  Others                           1.458        (1.157--1.837)   0.001            0.845     0.174                   0.505                 
  Overall                          1.443        (1.319--1.578)   \<0.001          \<0.001   0.255                   0.642                 
  Recessive (G/G vs. A carriers)   Asian        1.476            (1.267--1.721)   \<0.001   0.003                   0.621                 0.506
  Caucasian                        1.770        (1.386--2.260)   \<0.001          \<0.001   0.791                   0.586                 
  Others                           1.487        (0.931--2.376)   0.097            0.773     0.174                   0.275                 
  Overall                          1.589        (1.396--1.808)   \<0.001          \<0.001   0.978                   0.965                 
  Dominant (G carriers vs. A/A)    Asian        1.431            (1.227--1.670)   \<0.001   0.349                   0.187                 0.196
  Caucasian                        1.727        (1.419--2.102)   \<0.001          \<0.001   0.344                   0.860                 
  Others                           1.739        (1.254--2.412)   0.001            0.850     1.000                   0.705                 
  Overall                          1.621        (1.430--1.837)   \<0.001          0.001     0.113                   0.166                 
